Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200905 (US9533999, i-39) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 39 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM50019905 (CHEMBL3287210 | US9533999, ii-4) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 41 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200937 (US9533999, ii-5) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 46 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200946 (US9533999, ii-8) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 47 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM50019903 (CHEMBL3287208 | US9533999, i-40) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 48 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM50019900 (CHEMBL3287205 | US9533999, i-5) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 49 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM50019904 (CHEMBL3287209 | US9533999, ii-1) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 52 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200942 (US9533999, ii-7) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 52 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200966 (US9533999, ii-17) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM50019906 (CHEMBL3287211 | US9533999, ii-11) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 66 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200973 (US9533999, ii-23) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 67 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200904 (US9533999, i-38) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 71 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200971 (US9533999, ii-22) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 73 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200855 (US9533999, i-12) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 77 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200862 (US9533999, i-18) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 88 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200858 (US9533999, i-15) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 92 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM50019901 (CHEMBL3287206 | US9533999, i-34) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 96 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200852 (US9533999, i-9) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200894 (US9533999, i-33) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200840 (US9533999, i-2) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200930 (US9533999, i-43) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200947 (US9533999, ii-9) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200842 (US9533999, i-4) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200929 (US9533999, i-42) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200955 (US9533999, ii-13) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200870 (US9533999, i-23) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200965 (US9533999, ii-16) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200841 (US9533999, i-3) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200853 (US9533999, i-10) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200935 (US9533999, ii-3) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200923 (US9533999, i-41) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 190 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200900 (US9533999, i-37) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 230 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200896 (US9533999, i-35) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 240 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200865 (US9533999, i-21) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 240 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200967 (US9533999, ii-18) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 250 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200952 (US9533999, ii-12) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 260 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200839 (US9533999, i-1) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 290 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200879 (US9533999, i-27) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 310 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200948 (US9533999, ii-10) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 310 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200933 (US9533999, ii-2) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 320 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200968 (US9533999, ii-19) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 340 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200846 (US9533999, i-7) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 350 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200861 (US9533999, i-17) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 350 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200899 (US9533999, i-36) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 380 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200970 (US9533999, ii-21) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 400 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200864 (US9533999, i-20) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 490 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200964 (US9533999, ii-15) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 490 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200874 (US9533999, i-26) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 510 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200969 (US9533999, ii-20) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 510 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM200856 (US9533999, i-13) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 830 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ... | US Patent US9533999 (2017) BindingDB Entry DOI: 10.7270/Q21V5C4S | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 64 total ) | Next | Last >> |